| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Otolaryngology |
0 |
0.97 |
| Esophageal Adenocarcinoma |
0 |
0.99 |
| Surgery |
0 |
0.56 |
| Esophageal Cancer |
0 |
0.5 |
| Biologic Therapy |
0 |
0.46 |
| Esophagus |
0 |
0.4 |
| Neoadjuvant Therapy |
0 |
0.35 |
| Adenocarcinoma |
0 |
0.28 |
| Chemotherapy |
0 |
0.28 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.26 |
| Cancer |
0 |
0.24 |
| Immunotherapy |
0 |
0.24 |
| Gastric Cancer |
0 |
0.2 |
| Toxicology |
0 |
0.2 |
| Germany |
0 |
0.12 |
| Radiation Therapy |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Adjuvant Therapy |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Perioperative Care |
0 |
0.08 |
| Postoperative |
0 |
0.08 |